Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,142.00
Bid: 2,140.00
Ask: 2,144.00
Change: 66.00 (3.18%)
Spread: 4.00 (0.187%)
Open: 2,084.00
High: 2,148.00
Low: 2,084.00
Prev. Close: 2,076.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Derwent London Secures West End Planning Consents

21 Nov 2017 12:30

RNS Number : 1154X
Derwent London PLC
21 November 2017
 

21 November 2017

 

Derwent London plc ("Derwent London" / "the Group")DERWENT LONDON SECURES TWO WEST END PLANNING CONSENTS 

 

Derwent London is pleased to announce that the City of Westminster has resolved to grant planning permission on two projects totalling 443,000 sq ft. The first is a major mixed-use development at 19-35 Baker Street W1 and the second is for a significant retail-led project at Holden House, Oxford Street W1.

 

19-35 Baker Street W1 is held in a joint venture, in which Derwent London has a 55% share, with The Portman Estate. This scheme will comprise c.293,000 sq ft of net lettable space.

 

Holden House, 54-68 Oxford Street and 51-58 Rathbone Place W1 will comprise a 150,000 sq ft redevelopment behind a retained façade. There is potential for a single flagship retail store or a retail-led scheme with offices at the fast improving eastern end of Oxford Street.

 

John Burns, Chief Executive Officer of Derwent London, said:

"Given the excellent progress we have seen with our on-site projects this year we are delighted to receive resolutions to grant consent for these two potential pipeline schemes. Delivery could be phased into the early years of the next decade while, in the short term, we will continue to benefit from the income on the existing space."

 

- ends -

 

For further information, please contact:

 

 Derwent London

 Tel +44 (0)20 7659 3000

 

John Burns, Chief Executive Officer

Paul Williams, Director

Quentin Freeman, Head of Investor Relations

 

 

 Brunswick Group LLP

 Tel: +44 (0)20 7404 5959

Tim Danaher

Emily Trapnell

 

 

 

Notes to editors

 

 

Derwent London plc

Derwent London plc owns 89 buildings in a commercial real estate portfolio predominantly in central London valued at £4.8 billion (including joint ventures) as at 30 June 2017, making it the largest London-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our 5.6 million sq ft portfolio include Angel Building EC1, The Buckley Building EC1, White Collar Factory EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

In 2017 the Group won Property Week Developer of the Year and EG Offices Company of the Year and won further awards from the RIBA, Civic Trust and BCO and is listed 12th in the Corporate Knights Global 100 of the world's most sustainable companies. In 2013 Derwent London launched a voluntary Community Fund and has to date supported 50 community projects in Fitzrovia and the Tech Belt.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMMZMZMFGNZM
Date   Source Headline
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company
28th Feb 20224:45 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSResults for the Year Ended 31 December 2021
31st Jan 20224:45 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSSALE OF NEW RIVER YARD EC1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.